TY - JOUR
T1 - Surgical Techniques for Abdominoperineal Resection for Rectal Cancer
T2 - One Size Does Not Fit All
AU - Wilkins, Simon
AU - Yap, Raymond
AU - Mendis, Shehara
AU - Carne, Peter
AU - McMurrick, Paul J.
N1 - Funding Information:
We thank Let's Beat Bowel Cancer ( www.letsbeatbowelcancer.com ) for financial support during this project.
Publisher Copyright:
Copyright © 2022 Wilkins, Yap, Mendis, Carne and McMurrick.
PY - 2022/2/24
Y1 - 2022/2/24
N2 - Abdominoperineal resection (APR) of rectal cancer is associated with poorer oncological outcomes than anterior resection. This may be due to higher rates of intra-operative perforation (IOP) and circumferential resection margin (CRM) involvement causing higher recurrence rates and surgical complications. To address these concerns, several centers advocated a change in technique from a standard APR to a more radical extra-levator abdominoperineal excision (ELAPE). Initial reports showed that ELAPE reduced IOP rates and CRM involvement but increased wound complications and longer surgical duration. However, many of these studies had unacceptable rates of IOP and CRM before retraining in ELAPE. This may indicate that it was a sub-optimal surgical technique, which improved upon training, that had influenced the high CRM and IOP rates rather than the technique itself. Subsequent studies demonstrated that the CRM involvement rate for ELAPE was not always lower than for standard APR and, in some cases, significantly higher. The morbidity of ELAPE can be high, with studies reporting higher adverse events than APR, especially in terms of wound complications from the larger perineal incision required in ELAPE. Whether ELAPE improves short- or long-term oncological outcomes for patients has not been clearly demonstrated. The authors propose that all centers performing rectal cancer surgery audit surgical outcomes of patients undergoing APR or ELAPE and examine CRM involvement, IOP rates, and local recurrence rates, preferably through a national body. If rates of adverse technical or oncological outcomes exceed acceptable levels, then retraining in the appropriate surgical techniques may be indicated.
AB - Abdominoperineal resection (APR) of rectal cancer is associated with poorer oncological outcomes than anterior resection. This may be due to higher rates of intra-operative perforation (IOP) and circumferential resection margin (CRM) involvement causing higher recurrence rates and surgical complications. To address these concerns, several centers advocated a change in technique from a standard APR to a more radical extra-levator abdominoperineal excision (ELAPE). Initial reports showed that ELAPE reduced IOP rates and CRM involvement but increased wound complications and longer surgical duration. However, many of these studies had unacceptable rates of IOP and CRM before retraining in ELAPE. This may indicate that it was a sub-optimal surgical technique, which improved upon training, that had influenced the high CRM and IOP rates rather than the technique itself. Subsequent studies demonstrated that the CRM involvement rate for ELAPE was not always lower than for standard APR and, in some cases, significantly higher. The morbidity of ELAPE can be high, with studies reporting higher adverse events than APR, especially in terms of wound complications from the larger perineal incision required in ELAPE. Whether ELAPE improves short- or long-term oncological outcomes for patients has not been clearly demonstrated. The authors propose that all centers performing rectal cancer surgery audit surgical outcomes of patients undergoing APR or ELAPE and examine CRM involvement, IOP rates, and local recurrence rates, preferably through a national body. If rates of adverse technical or oncological outcomes exceed acceptable levels, then retraining in the appropriate surgical techniques may be indicated.
KW - abdominoperineal resection
KW - Colorectal Cancer
KW - extra-levator abdominoperineal excision (ELAPE)
KW - surgical outcome
KW - surgical technique
UR - http://www.scopus.com/inward/record.url?scp=85126261939&partnerID=8YFLogxK
U2 - 10.3389/fsurg.2022.818097
DO - 10.3389/fsurg.2022.818097
M3 - Article
C2 - 35284486
AN - SCOPUS:85126261939
VL - 9
JO - Frontiers in Surgery
JF - Frontiers in Surgery
SN - 2296-875X
M1 - 818097
ER -